semaglutide vs liraglutide weight loss over 18 months. Semaglutide users saw greater reductions in body compared to those on liraglutide. Persistent medication coverage is key! #Obesity #WeightLoss #DiabetesResearch #GLP1RA https://t.co/Grk5XMVgF3 GLP-1 Shots vs Liraglutide: Which

The FDA label recommends that women using oral hormonal contraceptives switch to a non-oral contraceptive method or add a barrier method for 4 weeks after initiation and for 4 weeks after each dose escalation of tirzepatide

The OCR even mentioned studies showing it reduced body weight, BMI, and fat mass which aligns with what I was hoping for

The extra 30 seconds prevents dosing errors that could affect your entire week

September 17 Product: Novartis Kisqali Indication : Breast cancer Novartis has approximately doubled the eligible patient population for its Kisqali in breast cancer, as the FDA greenlit a label expansion of the drug, in combination with an aromatase inhibitor, for earlier stages of the disease

The SELECT trial was the first large, randomized study to show that a drug used for obesity could reduce cardiovascular disease, says Isaacs